Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Lab to Market Translation_SBIR/STTR, SBA Loans, Accelerators, Clinical Trial Programs, Entrepreneurship Programs, Technology Transfer (T2), Commercialization, Life Cycle Management, Small Business Set Asides, Dissemination and Implementation (D&I) Science, Pilot Projects, Acquisition, Procurement & Contracting_SMEs
*Key People: Triple Helix
**Key People: Intermediaries - T2 (Technology Transfer), Capital, Business Development, Commercialization, Procurement / Acquisition & Law
*Key People: Angel, Venture Capital & Private Equity

*Key People: Intellectual Ventures

Parents

110 employees, about equally divided among attorneys, technologists, and business staff.
Bran Ferren, Applied Minds, Inc.
Brent Frei, EVP
Casey Tegreene, Chief Patent Officer
Danny Hillis, Applied Minds
Dr Ed Harlow, Chair, Department of Molecular BioChemistry, Harvard Medical School
Dr Edward Boyden, Phd, Professor, Co-Director, MIT Center for Neurobiological Engineering, formerly, Stanford (2025)
Dr Eric Leudhart, MD, Barnes-Jewish Medical Center
Dr Ken Deffeyes, Professor Emeritus, Princeton
Dr Leroy Hood, MD, Phd, President, Institute of Systems Biology (2026)
Dr Michael Smith, MD, Thoracic Surgery, USC
Dr Robert Langer, Phd, Germeshausen Professor of Chemical & Biomedical Engineering, David H. Koch Institute, MIT (2026)
Edward Jung
Hawkins, the new vice president of business development (2010)
Karen Kerr, Intellectual Ventures (2010)
Lowell Wood, Livermore Laboratories
Nathan Myhrvold, CEO, Intellectual Ventures
Patrick Ennis, Global Head of Technology, Intellectual Ventures
Peter Detkin, Managing Director
Sir John Pendry, Imperial College